Daily Newsletters
Account
Washington Evening Journal
111 North Marion Avenue
Washington, IA 52353
319-653-2191
UnityPoint leverages cutting-edge neoprobe technology
GRINNELL — UnityPoint Health-Grinnell recently announced the availability of the Neoprobe Gamma Detection System technology by Mammotome.
Anna Mensing, a general and breast surgeon at the Grinnell General Surgery and Weight Loss Surgery Clinic, is now using Neoprobe to provide patients with a more precise and personalized approach to their breast cancer diagnosis and treatment.
A Neoprobe is an imaging device surgeons use to pinpoint cancerous tissue during surgery. This innovative technology allows doctors o gain a clearer picture of affected tissue tumor during surgery, leading to improved diagnosis and treatment planning for breast cancer patients.
Enhanced Accuracy: Neoprobe provides a more accurate view of the affected tissue, potentially leading to a more precise and less invasive surgery, UnityPoint says. This can also lead to lower complications and better patient outcomes.
Personalized Care: By offering a clearer picture, the Neoprobe allows for a more personalized treatment plan tailored to each patient's specific needs.
Local Access to Cutting-Edge Care: UnityPoint Health-Grinnell understands the importance of convenient access to high-quality health care. By offering the Neoprobe technology locally, patients can receive advanced care close to home, reducing stress and travel burdens, says UnityPoint.
To learn more, talk with a primary care provider or call the UnityPoint Health-Grinnell General Surgery and Weight Loss Surgery Clinic at 641-236-4323.
